Государственное Учреждение "Институт Глазных Болезней И Тканевой Терапии Им. В.П. Филатова Академии Медицинских Наук Украины"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Государственное Учреждение "Институт Глазных Болезней И Тканевой Терапии Им. В.П. Филатова Академии Медицинских Наук Украины"filedCriticalГосударственное Учреждение "Институт Глазных Болезней И Тканевой Терапии Им. В.П. Филатова Академии Медицинских Наук Украины"
Priority to UAU200907988UpriorityCriticalpatent/UA46301U/en
Publication of UA46301UpublicationCriticalpatent/UA46301U/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
A method for treating maculodystrophy due to rhegmatogenous detachment of the retina provides for postoperative administration of Oxybral at a dose of 30 mg twice a day after the meals for 2 months.
UAU200907988U2009-07-292009-07-29Method for treating maculodystrophy due to rhegmatogenous detachment of retina
UA46301U
(en)